The U.S. Department of Energy has announced a $1M SBIR Phase II grant award for a collaboration between Industrial Microbes and Opus 12 to facilitate the integration of Industrial Microbes’s methane-to-industrial-chemicals platform with Opus 12’s CO2-to-methane platform.
The companies’ combined technology addresses remediation of the two most important GHG gases: CO2 and methane. “By conversion of CO2 and methane into industrially relevant chemicals in a cost competitive manner, we will have a major impact on global warming,” said Derek Greenfield, Founder and CEO of Industrial Microbes.
In the first phase of the project, the two teams demonstrated that their technologies could be combined to catalyze the conversion of CO2 and methane contained in biogas into a high-value product. This new funding enables the partners to accelerate scale-up and validation of their breakthrough technology.
Through this project, the capture and reuse of greenhouse gases will be incentivized by the value of the final product.
The target product for this program, which has not been disclosed, is a versatile chemical intermediate for the materials sector with a market potential in excess of $20B per year. As part of the program, the companies will demonstrate a physical prototype of the commercial process that will convert simulated biogas into the valuable chemical at high carbon efficiency.
“There is a clear trend towards sustainability in the materials sector. Consumers care about their carbon footprints more every day, but at the same time, there is resistance to paying higher prices for greener products,” said Dr. Noah Helman, Founder and Head of Business Development at Industrial Microbes. “This project is a trailblazer for how to make a profitable chemical product using a carbon-negative process.”